Natixis’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-65,000
Closed -$10.9M – 1019
2022
Q4
$10.9M Buy
+65,000
New +$11.3M 0.06% 257

Other funds holding CME

Natixis's CME Position: Q2 2026 in Review

Natixis increased its CME Group (CME) stake by 400% in Q2 2026, buying an estimated $6.72M and bringing the position to 30,347 shares worth $6.7M. The position accounts for 0.03% of the portfolio, ranked #378.

Natixis first reported a position in CME in Q2 2013 and has held it in 45 quarters since. The position peaked at $70.5M in Q3 2019. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Natixis held 30,347 shares of CME Group worth $6.7M as of Q2 2026.
  • Natixis bought 24,279 CME Group shares in Q2 2026, an estimated $6.72M.
  • CME Group made up 0.03% of Natixis's portfolio in Q2 2026, its #378 holding.
  • Natixis first reported a position in CME Group in Q2 2013 and has held it in 45 quarters since.
  • Natixis's CME Group position peaked at $70.5M in Q3 2019.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.